X-TROZINE Drug Patent Profile
✉ Email this page to a colleague
When do X-trozine patents expire, and when can generic versions of X-trozine launch?
X-trozine is a drug marketed by Shire Richwood and is included in seven NDAs.
The generic ingredient in X-TROZINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for X-trozine
A generic version of X-TROZINE was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for X-TROZINE?
- What are the global sales for X-TROZINE?
- What is Average Wholesale Price for X-TROZINE?
Summary for X-TROZINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 20 |
| DailyMed Link: | X-TROZINE at DailyMed |
US Patents and Regulatory Information for X-TROZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shire Richwood | X-TROZINE | phendimetrazine tartrate | CAPSULE;ORAL | 087394-001 | Sep 22, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Shire Richwood | X-TROZINE L.A. | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 087371-001 | Aug 24, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Shire Richwood | X-TROZINE | phendimetrazine tartrate | TABLET;ORAL | 086552-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Shire Richwood | X-TROZINE | phendimetrazine tartrate | TABLET;ORAL | 086550-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
